DANCR and pachyonychia congenita: They found that DANCR positively regulates Ldha by competitively binding to miR-33B-5P, thereby promoting paclitaxel resistance in PC cells [79]; additionally, treatments incorporating docetaxel (DTX) as a standard anticancer agent have produced survival advantages for patients with castration-resistant PC.